Evidence map›Paper›PMID 33125562›Full record

ArticleEuropean radiology2021

Are lesion features reproducible between

Cláudia S Constantino, Francisco P M Oliveira, Mariana Silva, Carla Oliveira, Joana C Castanheira, Ângelo Silva, Sofia C Vaz, Pedro Vieira, Durval C Costa

Abstract read
PubMed Publisher
In one paragraph

Article in European radiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.0field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 15 citations in OpenAlex.

  1. Advances in radiation oncology · 2026
    Article
  2. An AI-Based Solution for Denoising Fast-Acquisition [Journal of imaging informatics in medicine · 2026
    Article
  3. Baseline [European journal of nuclear medicine and molecular imaging · 2024
    Article
  4. Review
  5. Article
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Cláudia S ConstantinoNuclear Medicine - Radiopharmacology, Champalimaud Centre for the Unknown, Champalimaud Foundation, Av. Brasília, 1400-038, Lisbon, Portugal. claudia.constantino@research.fchampalimaud.org.ORCID http://orcid.org/0000-0003-4320-8437
Francisco P M OliveiraNuclear Medicine - Radiopharmacology, Champalimaud Centre for the Unknown, Champalimaud Foundation, Av. Brasília, 1400-038, Lisbon, Portugal.
Mariana SilvaNuclear Medicine - Radiopharmacology, Champalimaud Centre for the Unknown, Champalimaud Foundation, Av. Brasília, 1400-038, Lisbon, Portugal.
Carla OliveiraNuclear Medicine - Radiopharmacology, Champalimaud Centre for the Unknown, Champalimaud Foundation, Av. Brasília, 1400-038, Lisbon, Portugal.
Joana C CastanheiraNuclear Medicine - Radiopharmacology, Champalimaud Centre for the Unknown, Champalimaud Foundation, Av. Brasília, 1400-038, Lisbon, Portugal.
Ângelo SilvaNuclear Medicine - Radiopharmacology, Champalimaud Centre for the Unknown, Champalimaud Foundation, Av. Brasília, 1400-038, Lisbon, Portugal.
Sofia C VazNuclear Medicine - Radiopharmacology, Champalimaud Centre for the Unknown, Champalimaud Foundation, Av. Brasília, 1400-038, Lisbon, Portugal.
Pedro VieiraPhysics Department, NOVA School of Science and Technology, Lisbon, Portugal.
Durval C CostaNuclear Medicine - Radiopharmacology, Champalimaud Centre for the Unknown, Champalimaud Foundation, Av. Brasília, 1400-038, Lisbon, Portugal.
Champalimaud Foundation · PTUniversidade Nova de Lisboa · PT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo compare lesion features extracted from

methodsWhole-body

resultsIn total, 323

conclusionUnder controlled acquisition and reconstruction parameters, most of the features studied can be used for research and clinical work. This is especially important for multicenter studies and patient follow-ups. KEY POINTS: • Using manufacturer standard clinical reconstruction protocols, lesions SUV was significantly higher when using the digital scanner, especially the SUV

Indexed as

Fluorodeoxyglucose F18Positron Emission Tomography Computed TomographyGlycolysisHumansImage Processing, Computer-AssistedPositron-Emission TomographyRadiopharmaceuticalsTomography Scanners, X-Ray ComputedTumor BurdenFluorodeoxyglucose F18Radiopharmaceuticals18F-FDG PET/CTComputer-assisted image analysisDiagnostic imagingImage reconstructionReproducibility of results

Identifiers

PMID33125562
OpenAlexW3097841242

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.